Picture of Mithra Pharmaceuticals SA logo

MITRA Mithra Pharmaceuticals SA Share Price

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-51.14%
3m-55.7%
6m-77.06%
1yr-80.57%
Volume Change (%)
10d/3m+248.82%
Price vs... (%)
52w High-84.91%
50d MA-43.87%
200d MA-64.87%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-13.63%
Return on Equity-575.59%
Operating Margin-62.11%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Mithra Pharmaceuticals SA EPS forecast chart

Profile Summary

Mithra Pharmaceuticals SA is a Belgian-based company active in the pharmaceutical industry. The Company is a biotech company providing solutions in a field of women’s health, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. The Company provides three development candidates built on Mithra’s estrogen platform, Estetrol (E4): Estelle, a solution for oral contraception, PeriNesta, the oral treatment targeting perimenopause and Donesta, a hormone therapy. The Company also develops and manufactures therapeutics in the areas of contraception, menopause and hormone-dependent cancers. It offers partners a spectrum of research, development and specialist manufacturing at its technological platform Mithra CDMO. The Company operates in more than 100 countries around the world and is headquartered in Liege, Belgium.

Directors

Last Annual
December 31st, 2022
Last Interim
June 30th, 2023
Incorporated
July 13th, 1999
Public Since
June 30th, 2015
No. of Employees
229
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
be flag iconEuronext - Brussels
Shares in Issue
66,908,397
Blurred out image of a map
Address
Rue Saint-Georges 5, LIEGE, 4000
Web
https://www.mithra.com/
Phone
+32 43492822
Auditors
BDO Reviseurs d Entreprises

MITRA Share Price Performance

Upcoming Events for MITRA

Full Year 2023 Mithra Pharmaceuticals SA Earnings Release

Full Year 2023 Mithra Pharmaceuticals SA Earnings Presentation

Mithra Pharmaceuticals SA Annual Shareholders Meeting

Mithra Pharmaceuticals SA Annual Shareholders Meeting

Similar to MITRA

Picture of Biosenic SA logo

Biosenic SA

be flag iconEuronext - Brussels

Picture of Fagron NV logo

Fagron NV

be flag iconEuronext - Brussels

Picture of Hyloris Pharmaceuticals SA logo

Hyloris Pharmaceuticals SA

be flag iconEuronext - Brussels

Picture of Financiere de Tubize SA logo

Financiere de Tubize SA

be flag iconEuronext - Brussels

Picture of UCB SA logo

UCB SA

be flag iconEuronext - Brussels

FAQ